SF
NVO

Sarofim Fayez’s Novo Nordisk NVO Stock Holding History

Sarofim Fayez’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$256M Buy
+15,125,920
New +$254M 1.25% 29

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $10.5B AUM 30.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Sarofim Fayez's NVO Position: Q3 2013 in Review

Sarofim Fayez opened a new position in Novo Nordisk (NVO) in Q3 2013: 15,125,920 shares worth $256M. The stake represents 1.25% of the portfolio and ranks #29 among its holdings.

425 funds tracked by Wall St. Rank hold NVO as of Q3 2013.

  • Sarofim Fayez held 15,125,920 shares of Novo Nordisk worth $256M as of Q3 2013.
  • Novo Nordisk was a new Sarofim Fayez position in Q3 2013.
  • Novo Nordisk made up 1.25% of Sarofim Fayez's portfolio in Q3 2013, its #29 holding.
  • 425 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2013.

Based on Sarofim Fayez's 13F filing for Q3 2013, filed 14 Nov 2013.